Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The procedure known as "antibody removal via extracorporeal filtration" encompasses several blood purification technologies, including plasmapheresis and immunoadsorption, that mechanically remove pathogenic antibodies from the plasma by filtering blood outside the body through specialized membranes, columns, or cartridges. Indicated primarily for conditions where circulating autoantibodies or immune complexes mediate disease, such as autoimmune disorders or antibody-mediated rejection, these procedures do not interact with a discrete molecular target but instead act broadly to reduce the antibody burden. Mechanisms involve physical separation, adsorption onto immobilized ligands, or exchange with replacement fluids. Safety challenges include immunodeficiency, hemodynamic changes, risk of allergy or bleeding, and technical complications inherent to extracorporeal circulation. The efficacy of these procedures depends on selective antibody removal, clinical context, and integration with adjunctive immunosuppressive therapies [1][2][3][4][5].
Physical removal of antibodies from plasma via filtration, adsorption, or exchange. Depletion of immunoglobulins and immune complexes to attenuate pathological immune responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antibody removal via extracorporeal filtration.